MAPT and Alzheimer disease: In Alzheimer’s disease, tau aggregation and phosphorylation changes correlate better with disease progression than amyloid beta pathology [2] despite clear genetic evidence linking amyloid beta to the disease [3], suggesting a complex process in which amyloid beta, pathological tau, immune activation, and synapse loss likely collaborate to drive disease.